Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Seminars in Cancer Biology|January 4, 2012
Targeting stroma to treat cancersBoris Engels, Donald A Rowley, Hans SchreiberSeminars in Cancer Biology|October 19, 2004
Inflammation as a tumor promoter in cancer inductionMary Philip, Donald A Rowley, Hans SchreiberNature Medicine|February 26, 2004
Bystander elimination of antigen loss variants in established tumorsMichael T Spiotto, Donald A Rowley, Hans SchreiberThe Journal of Clinical Investigation|March 5, 2008
IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancersBin Zhang, Theodore Karrison, Donald A Rowley, et al.European Journal of Immunology|February 21, 2003
C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serumChristian Beck, Karin Schreiber, Hans Schreiber, et al.Hematology/Oncology Clinics of North America|June 10, 2006
Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experimentsKarin Schreiber, Donald A Rowley, Gert Riethmüller, et al.Current Opinion in Immunology|February 7, 2006
The role of stroma in immune recognition and destruction of well-established solid tumorsPing Yu, Donald A Rowley, Yang-Xin Fu, et al.Oncoimmunology|June 22, 2012
A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growthFrank T Wen, Ronald A Thisted, Donald A Rowley, et al.Cancer Research|March 5, 2008
Equilibrium between host and cancer caused by effector T cells killing tumor stromaBin Zhang, Yi Zhang, Natalie A Bowerman, et al.Cancer Immunity|July 1, 2011
Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genesTerry H Wu, Karin Schreiber, Ainhoa Arina, et al.Pageof 8